Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary

Journal of Obstetrics and Gynaecology Research

Volumn 40, Issue 5, 2014, Pages 1197-1204

  Oseto, Kumiko ^a   Suzumori, Nobuhiro ^a   Nishikawa, Ryutaro ^a   Nishikawa, Hiroshi ^a   Arakawa, Atsushi ^a   Ozaki, Yasuhiko ^a   Asai, Hidekazu ^b   Kawai, Michiyasu ^c   Mizuno, Kimio ^d   Takahashi, Satoru ^a   Shirai, Tomoyuki ^d   Yamada Namikawa, Chisato ^a   Nakanishi, Makoto ^a   Kajiyama, Hiroaki ^d   Kikkawa, Fumitaka ^d   Sugiura Ogasawara, Mayumi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Tosei Municipal Hospital   (Japan)

^c TOYOHASHI MUNICIPAL HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone morphogenetic protein 2; Follistatin; Granulosa cell tumor; Inhibin; Ovarian tumor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CA 125 ANTIGEN; DNA; FOLLISTATIN; INHIBIN A; CARBOHYDRATE ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG; BMP2 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXL2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CODON; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FOXL2 GENE; GENE; GENE MUTATION; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MIDDLE AGED; MUTATIONAL ANALYSIS; OVARY TUMOR; PROTEIN EXPRESSION; VERY ELDERLY; YOUNG ADULT; BLOOD LEVEL; CLINICAL ARTICLE; GENE EXPRESSION; GERM CELL TUMOR; OVARY CANCER; PREOPERATIVE CARE; PREOPERATIVE PERIOD; TISSUE SECTION; CHEMISTRY; GENETICS; MUTATION;

ADULT; BONE MORPHOGENETIC PROTEIN 2; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOSA CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; OVARIAN NEOPLASMS;

EID: 84903590751     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/jog.12324     Document Type: Article

References (28)

1. Crisponi L, Deiana M, Loi A et al. The putative forkhead transcription factor FOXL2 is mutatedin blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001; 27: 159-166. (Pubitemid 32157442)
2. Schmidt D, Ovitt CE, Anlag K et al. The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 2004; 131: 933-942. (Pubitemid 38263207)
3. De Baere E, Dixon MJ, Small KW et al. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus in versus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 2001; 10: 1591-1600. (Pubitemid 32734311)
4. Beysen D, Vandesompele J, Messiaen L, De Paepe A, De Baere E. The human FOXL2 mutation database. Hum Mutat 2004; 24: 189-193. (Pubitemid 39095594)
5. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003; 21: 1180-1189. (Pubitemid 46594151)
6. East N, Alobaid A, Goffin F, Ouallouche K, Gauthier P. Granulosa cell tumour: A recurrence 40 years after initial diagnosis. J Obstet Gynaecol Can 2005; 27: 363-364.
7. Colombo N, Parma G, Zanagnolo V, Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol 2007; 25: 2944-2951. (Pubitemid 47123159)
8. Shah SP, Kobel M, Senz J et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009; 360: 2719-2729.
9. Kim MS, Hur SY, Yoo NJ, Lee SH. Mutational analysis of FOXL2 codon 134 in granulose cell tumour of ovary and other human cancers. J Pathol 2010; 221: 147-152.
10. Schrader KA, Gorbatcheva B, Senz J et al. The specificity of the FOXL2 c.402C>G somatic mutation:A survey of solid tumors. PLoS ONE 2009; 4: e7988.
11. Benayoun BA, Caburet S, Dipietromaria A et al. Functional exporation of the adult ovarian granulosa cell tumorassociated somatic FOXL2 mutation p.Cys134Trp (c.402C>G). PLoS ONE 2010; 5: e8789.
12. Rosario R, Araki H, Print CG, Shelling AN. The transcriptional targets of mutant FOXL2 in granulosa cell tumours. PLoS ONE 2012; 7: e46270.
13. Lima JF, Jin L, de Araujo ARC et al. FOXL2 mutations in granulosa cell tumors occurring in males. Arch Pathol Lab Med 2012; 136: 825-828.
14. Benayoun BA, Anttonen M, Lhote D et al. Adult ovarian granulosa cell tumor transcriptomics: Prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation. Oncogene 2013; 32: 2739-2746.
15. Kashimada K, Pelosi E, Chen H, Schlessinger D, Wilhelm D, Koopman P. FOXL2 and BMP2 act cooperatively to regulate Follistatin gene expression during ovarian development. Endocrinology 2011; 152: 272-280.
16. Maguer-Satta V, Bartholin L, Jeanpierre S et al. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFβ family. Exp Cell Res 2003; 282: 110-120. (Pubitemid 36259905)
17. Nakamura T, Hasegawa Y, Sugino K et al. Follistatin inhibits activin-induced differentiation of rat follicular granulosa cells in vitro. Biochim Biophys Acta 1992; 1135: 103-109.
18. Ren P, Chen F-F, Liu H-Y et al. High serum levels of follistatin in patients with ovarian cancer. J Int Med Res 2012; 40: 877-886.
19. Suzumori N, Sato M, Yoneda T, Ozaki Y, Takagi H, Suzumori K. Expression of secretory leukocyte protease inhibitor in women with endometriosis. Fertil Steril 1999; 72: 857-867. (Pubitemid 29505450)
20. Jamieson S, Fuller PJ. Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev 2012; 33: 109-144.
21. D'Angelo E, Mozos A, Nakayama D et al. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary. Mod Pathol 2011; 24: 1360-1367.
22. Jacobs I, Bast RC. The CA-125 tumour associated antigen: A review of the literature. Hum Reprod 1989; 4: 1-12. (Pubitemid 19069900)
23. Berek JS, Bast RC Jr. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection. Cancer 1995; 76: 2092-2096.
24. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: A singlechain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987; 84: 8282-8286.
25. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM. Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 2004; 18: 953-967. (Pubitemid 38429484)
26. Mattukrishna S, Tannetta D, Groome N, Sargent I. Activin and follistatin in female reproduction. Mol Cell Endocrinol 2004; 225: 45-56. (Pubitemid 39297054)
27. Ma Y, Ma L, Guo Q, Zhang S. Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients. J Exp Clin Cancer Res 2010; 29: 85.
28. McLean K, Gong Y, Choi Y et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 2011; 121: 3206-3219.